COMMUNIQUÉS West-GlobeNewswire

-
Sight Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024
22/02/2024 -
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
22/02/2024 -
Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate Cancer
22/02/2024 -
Ocugen, Inc. Announces Dosing Completion of Subjects with Stargardt in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410ST
22/02/2024 -
Health Catalyst Reports Fourth Quarter and Year End 2023 Results
22/02/2024 -
Galapagos announces full year 2023 results and outlook for 2024
22/02/2024 -
Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
22/02/2024 -
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
22/02/2024 -
Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline
22/02/2024 -
AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
22/02/2024 -
Compass Pathways to announce fourth quarter and year-end 2023 financial results on February 29, 2024
22/02/2024 -
Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis
22/02/2024 -
Paul Johnson to run from Los Angeles to New York City in World Record attempt benefiting veterans’ nonprofit Team Red, White & Blue (Team RWB)
22/02/2024 -
BRIGHT GREEN CORPORATION GAINS MOMENTUM FOR THEIR “DRUGS MADE IN AMERICA” PLATFORM WITH APPROVAL FOR THE RESEARCH, PRODUCTION AND MANUFACTURING OF ALL SCHEDULE I AND SCHEDULE II PLANT-BASED DRUGS
22/02/2024 -
Press Release: Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors
22/02/2024 -
Communiqué de presse : Le Conseil d’administration de Sanofi propose la nomination de Clotilde Delbos, Anne-Françoise Nesmes et John Sundy en qualité d’administrateurs indépendants
22/02/2024 -
MAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer
22/02/2024 -
Imugene Highlights Recent Achievements and Looks Ahead to Key Upcoming Immuno-oncology Catalysts
22/02/2024 -
Intrommune Therapeutics Presents Supporting Data Introducing a New Form of Food Allergy Treatment
22/02/2024
Pages